Ivan P. Gergel, EVP, Research & Development at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), sold 55,603 shares at $36.53 ($2.0M) on 2010-12-03, disclosed to the SEC on 2010-12-07.
Open-market sale of $2.0M ENDP by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.53 | 25,000 | $913K | 45.0% |
| 2 | $36.53 | 30,603 | $1.1M | 55.0% |
| Total | $36.53 avg | 55,603 | $2.0M | 100% |
| Filing → |
| NKTR | SELL | 2017-07-20 | $1.2M | — | Filing → |
| NKTR | SELL | 2017-07-13 | $1.9M | — | Filing → |
| NKTR | SELL | 2017-05-18 | $28K | — | Filing → |